PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Clinical trial NCT00446446 · COMPLETED

Trial details

NCT number: NCT00446446
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Carcinoma Head and Neck Cancer Metastases Metastatic Cancer Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck Oncology Squamous Cell Carcinoma Tumors

Start date: 2007-10-30
Primary completion: 2010-12-15
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.